Symptoms of Meares-Irlen/Visual Stress Syndrome in subjects diagnosed with Chronic Fatigue Syndrome by Loew, Stephen J. et al.
International Journal  
of Clinical and Health Psychology
www.elsevier.es/ijchp
International Journal of Clinical and Health Psychology (2014) 14, 87−92
1697-2600/$ - see front matter © 2013 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L. All rights reserved.
International Journal of 
Clinical and Health 
Psychology
Publicación cuatrimestral / Four-monthly publication ISSN 1697-2600
Volumen 14, Número 2
Mayo - 2014
Volume 14, Number 2
May - 2014
Director / Editor:
Juan Carlos Sierra
Directores Asociados / Associate Editors:
Stephen N. Haynes
Michael W. Eysenck
Gualberto Buela-Casal
ORIGINAL ARTICLE
Symptoms of Meares-Irlen/Visual Stress Syndrome in subjects 
diagnosed with Chronic Fatigue Syndrome
Stephen J. Loewa,*, Nigel V. Marshb, Kenneth Watsona
a University of New England, Australia 
b Sunway University, Malaysia
Received October 24, 2013; accepted February 10, 2014
*Corresponding author at: School of Science & Technology, Armidale, NSW 2351, Australia. 
 E-mail address: sloew@myune.edu.au (S.J. Loew).
Abstract Several diagnostic symptoms of the visual-processing deficit Meares-Irlen/Visual 
Stress Syndrome are remarkably similar to symptom manifestations reported by individuals with 
chronic fatigue syndrome (CFS). We surveyed the specific incidences of nine widely-recognised 
symptoms of visual stress (VS) in a group of subjects (n = 20) previously diagnosed with CFS. The 
presence of each symptom of VS in the CFS group was compared to its respective presence in 
both an age and sex matched healthy comparison group (n = 46), and an age and sex matched 
group comprised of individuals (n = 14) diagnosed with VS. Results showed the frequencies of all 
nine VS symptoms in the CFS-diagnosed group to be significantly higher (p = .032 – p < .0005) 
than in the comparison group, with only two symptoms being statistically less frequent in the 
CFS group than in the VS-diagnosed group. The average number of VS symptoms reported by 
the CFS group was also significantly higher than the comparison group, yet not significantly 
different from the VS group. Thus, the occurrence of VS symptoms in subjects diagnosed with 
CFS appears to be far greater than previously reported, which in turn may indicate the interplay 
of some yet to be identified underlying factor(s) common to both conditions.
© 2013 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L.  
All rights reserved.
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Resumen Algunos síntomas del Síndrome de Estrés Visual/Meares-Irlen son similares a los in-
formados por individuos con síndrome de fatiga crónica (SFC). Se evaluó la incidencia de nueve 
síntomas ampliamente reconocidos de estrés visual (EV) en un grupo de sujetos (n = 20) con 
síndrome de fatiga crónica. La presencia de cada síntoma de EV en el grupo con SFC se comparó 
con un grupo control de sujetos sanos (n = 46) y con un grupo de individuos (n = 14) con diagnós-
tico de EV, equiparables en sexo y edad. Los resultados mostraron una frecuencia en los nueve 
síntomas de EV en el grupo diagnosticado SFC significativamente mayor (p = 0,032-p < 0,0005) 
que en el grupo de comparación, con sólo dos síntomas estadísticamente menos frecuentes en 
el grupo SFC que en el grupo EV. El número medio de síntomas EV señalados por el grupo SFC 
también fue significativamente mayor que el del grupo de comparación, aunque no significati-
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During the past two decades, there has been converging 
evidence of visual processing problems which can affect 
reading ability and are the primary pathology present in as 
many as one in four cases of dyslexia (Ramus et al., 2003; 
White et al., 2006). Visual stress (VS), also known as 
Meares-Irlen syndrome or scotopic sensitivity syndrome, is 
a visual processing deficit believed to affect at least 5% of 
the general population (Allen & Hollis, 2008; Kriss & Evans, 
2005). While fMRI studies have indicated that hyper-
excitability of the visual cortex is observable in subjects 
with VS (Huang et al., 2011), other studies have produced 
evidence of aberrant visual-signal processing en route to 
the visual cortex via the magnocellular pathway (Solan, 
Shelley-Tremblay, Hansen, & Larson, 2007; Stein, 2003), 
though it stands to reason that the latter might give rise to 
the former. Moreover, the ‘magnocellular theory’ has been 
questioned by some, in part because a large number of 
non-dyslexic individuals also have magnocellular deficits 
(Allen, Evans, & Wilkins, 2012; Skoyles & Skottun, 2004, 
2008). 
The key characteristics of VS include visual distortions of 
print when reading, such as the text appearing to move or 
vibrate, with these symptoms occurring despite an absence 
of optometric or ophthalmological abnormalities (Robinson, 
1994; Stein, 2003). An additional hallmark of VS is that an 
individual’s span of word recognition (the number of words 
seen in one eye fixation) is significantly reduced, as is their 
ability to maintain extended reading (Loew & Watson, 
2012b; Robinson, 1994). Symptoms of VS are also known to 
be exacerbated by fluorescent lighting (Loew, Fernández, 
& Watson, 2013; Winterbottom & Wilkins, 2009) and the 
use of coloured filters has frequently been reported as an 
effective means of ameliorating these symptoms (Allen et 
al., 2012; Loew & Watson, 2012b; Wilkins & Evans, 2009), 
while others have found no measurable benefits to reading 
(Ritchie, Della Sala, & McIntosh, 2011). 
Estimates of the prevalence of VS in the general 
population vary from 5% using very strict criteria, such as 
an immediate improvement in reading speed of 25% or 
greater when a subject reads through coloured overlays 
(Kriss & Evans, 2005), to as high as 22% when the reported 
symptom levels of VS form the basis of diagnosis (Allen & 
Hollis, 2008; Robinson, Hopkins, & Davies, 1995), while 
there appears to be general consensus of a 12% occurrence 
of moderate symptoms of VS. A number of studies have 
referred to VS as a sub-type of dyslexia (Sparkes, Robinson, 
Roberts, & Dunstan, 2006), however this categorisation 
remains highly contentious. Others describe VS as a 
separate entity which can occur with or without dyslexia, 
albeit significantly more prevalent (31-46%) in the dyslexic 
population (Irlen, 1994; Kriss & Evans, 2005; Kruk, Sumbler, 
& Willows, 2008). It is also significant that, although fewer 
in number, most studies of VS morbidity in adult populations 
have reported virtually identical incidences to those 
observed in children and adolescents (Evans & Joseph, 
2002; Robinson & Conway, 2000). 
Although symptoms of VS inherently affect reading, 
writing, spelling and visual attention, the degree of impact 
upon literacy and learning can vary greatly amongst 
affected individuals. This variation may in large part be due 
to the severity of VS morbidity being a continuum (Evans & 
Joseph, 2002), but it also is likely to occur because the 
condition is equally prevalent across all levels of intellectual 
ability and many individuals are thus able to compensate 
for their inefficient reading. As a result, the few overt 
symptoms of VS, such as a dislike of reading aloud, poor 
handwriting and inattentiveness, might easily be 
misinterpreted as laziness or being signs of other learning 
disorders by parents, teachers and physicians.
The epidemiology of VS is complicated by the fact that 
similar or identical symptoms have been identified in a 
number of independent disorders, including: developmental 
dyslexia (Northway, Manahilov, & Simpson, 2010; Rodríguez-
Pérez, González-Castro, Álvarez, Álvarez, & Fernández-
Cueli, 2012; Wright & Conlon, 2009); attention deficit/
hyperactivity disorder (ADHD) (Loew & Watson, 2013; 
Taurines et al., 2010); autism spectrum disorders (Ludlow, 
Taylor-Whiffen, & Wilkins, 2012); migraine and 
photosensitive epilepsy (Wilkins, Huang, & Cao, 2007); and 
chronic fatigue syndrome (CFS) (Loew & Watson, 2012a; 
Robinson, McGregor, Roberts, Dunstan, & Butt, 2001). 
Although unusually high rates of comorbidity with VS have 
been confirmed in dyslexia, ADHD, migraine and autism, 
further investigative studies of VS comorbidity or symptom 
overlap in CFS are lacking. 
Some researchers of CFS epidemiology, such as Robinson 
et al. (2001), have reported exceptionally high incidences 
of VS comorbidity in their CFS subjects. However, follow-up 
studies aimed at directly measuring the degree of symptom 
overlap between the VS and CFS disorders appear to be 
limited if not absent from the scientific literature. CFS 
pathology does, however, occupy a sizeable portion of the 
literature pertaining to human neurobiological disorders. In 
contrast to the VS condition, CFS is a debilitating disorder 
that is characterised by continual and incapacitating 
fatigue, muscle and joint pain, and impaired cognitive 
function. Estimates of CFS prevalence in the population are 
in the order of 0.25% (Reyes et al., 2003). According to the 
Australasian College of Physicians, the diagnostic criteria 
for CFS are: Unexplained incapacitating fatigue for at least 
six months, plus any four of the following symptoms: 
Impaired memory or concentration; Joint pain; Sore throat; 
Headaches; Tender glands; Unrefreshing sleep; Muscle pain; 
Post-exertional malaise.
vamente diferente el grupo EV. Por lo tanto, la presencia de los síntomas de EV en sujetos con 
diagnóstico de SFC parece ser mucho mayor que la informada, lo que puede indicar la interac-
ción de algún factor/s subyacente/s aún no identificado/s comunes a ambas condiciones.
© 2013 Asociación Española de Psicología Conductual. Publicado por Elsevier España, S.L.  
Todos los derechos reservados.
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Though classed as separate disorders, many widely 
utilised diagnostic criteria for CFS (i.e. ME/CFS Guidelines: 
Canadian Clinical Criteria, 2003) include a notable number 
of visual perception and visual attention symptoms that are 
also recognised diagnostic criteria for VS. It is therefore 
somewhat surprising that investigations of symptom overlap 
between these separately categorised human disorders 
appear to be under-represented in the literature. This is 
especially pertinent upon noting that clearly defined causal 
mechanisms for either of these conditions remain elusive. 
The present study endeavours to ascertain the presence of 
diagnostic symptoms of VS in subjects diagnosed with CFS 
and then compare these to their respective frequencies in 
a healthy comparison group, and in a group of subjects 
diagnosed with the VS condition itself. 
Method
Participants
The data utilised in this study was obtained from a sample 
of 80 university students and academics recruited from the 
University of New England, Australia. There were three 
groups of participants in the current study: Individuals (n = 
20) medically diagnosed with CFS, individuals (n = 14) with 
diagnoses of VS by certified Irlen/VS screeners, and a 
comparison group (n = 46) with no histories of CFS, VS, or 
ADHD. The CFS and comparison groups were matched for 
age and gender. The difference in average age between the 
CFS group (M = 36.50, SD = 11.60 years) and the comparison 
group (M = 31.00, SD = 10.19) was not statistically significant 
(t(64) = 1.93, p > .05), and the difference in sex composition 
between the CFS group (75% female) and the comparison 
group (74% female) was not statistically significant (χ2(1) = 
0.01, p > .05).
The CFS and VS groups were also matched for age and 
gender. The difference in average age between the CFS 
group (M = 36.50, SD = 11.60 years) and the VS group (M = 
34.21, SD = 9.80) was not statistically significant (t(32) = 
0.60, p > .05). Similarly, the difference in sex composition 
between the CFS group (75% female) and the VS group (50% 
female) was also not statistically significant (χ2(1) = 2.25, 
p > .05). All participants were from similar sociological and 
academic backgrounds and, despite some variation in 
monetary incomes, none of the participants reported 
backgrounds fitting the definition of lower socio-economic 
status. Prior to inclusion in the study, each of the 
participants were interviewed and fully informed of 
the study’s protocol before signing an informed consent form. 
There were no part ic ipant  appl icants  with 
ophthalmological conditions, or optometric problems which 
had not recently (< 2 years) been corrected. None of the 
participants had been treated for any psychological or 
mood disorders or prescribed any form of psychotropic 
medication in the two years prior to the interview, thus it 
was not necessary to exclude any of the applicants on these 
bases. Each of the participants included in the CFS group 
(n = 20) reported as having a prior medical diagnosis of CFS 
attributed by the Australian healthcare system, and not 
having any reading or visual perception problems. The 
participants included in the VS group (n = 14) reported a 
previous diagnosis of VS from a certified Irlen/VS screener 
or diagnostician, and no prior history of CFS. The current 
validity of a participant’s VS diagnosis was verified in a pre-
trial VS screening by a certified VS/Irlen screener (Loew). 
However, CFS symptoms in the VS group were not screened 
as a qualified CFS diagnostician was not readily available to 
assess symptoms of CFS in the time-frame in which most of 
the participants were available for interview.
Instruments
The participants completed a self-report questionnaire 
designed to survey the incidences of nine diagnostic 
symptoms of VS (Table 1) as per those described by Kruk et 
al. (2008), Whiting, Robinson, and Parrott (1994), and the 
Irlen Reading Perceptual Scale (Irlen, 1994). For each 
symptom, participants were required to indicate whether 
they have the symptom on a 3-point scale of: Yes, No, or 
Sometimes. For the purposes of data analysis, responses of 
Yes and Sometimes were classified as indicating the 
presence of a symptom. Therefore, the range of possible 
scores was from 0 to 9. 
Procedure and data analysis
The aim of the study was to examine the presence of VS 
symptoms in individuals diagnosed with CFS in comparison 
to (a) a “normal” comparison group and (b) a group 
diagnosed with VS, and provide analysis of data in a non-
complex format (Hartley, 2012). A one-way between groups 
ANOVA with post-hoc tests was utilised to examine 
differences between the three groups on total symptoms of 
VS. Analysis of differences between the CFS group and each 
of the other two groups for specific symptoms of VS was 
undertaken by chi-square tests for independence. Ethics 
approval was granted by the University of New England 
Human Research Ethics Committee (approval: HE12-108). 
The study was conducted in accordance with the Code of 
Ethics of the World Medical Association (Declaration 
of Helsinki, 2008) for research involving humans. 
Results
A one-way between-groups analysis was conducted to 
examine the differences between the three groups on their 
respective total scores on the questionnaire. There was a 
statistically significant difference in total VS symptom 
score for the three groups, F(2, 77) = 26.15, p < .001. Post-hoc 
comparisons using the Tukey HSD test indicated that the 
mean score for the comparison group (M = 2.28, SD = 2.13) 
was significantly different from the mean score for both 
the CFS group (M = 5.60, SD = 2.64, p < .0005) and the VS 
group (M = 6.64, SD = 2.50, p < .0005). In contrast, the 
difference between the mean scores for the CFS and VS 
groups was not statistically significant (p > .05).
Prevalence of visual stress symptoms in the chronic 
fatigue syndrome and comparison groups
As the data presented in Table 1 shows, the incidences of 
all nine symptoms of VS were far more prevalent in the CFS 
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group (frequencies ranging from 50 to 85%), than their 
corresponding incidences in the comparison group 
(frequencies ranging from 7 to 44%). All between- 
group differences in the occurrence of each symptom were 
statistically significant. With respect to the typical number 
of VS symptoms present in the CFS-diagnosed participants, 
15 (75%) of the subjects in the CFS group reported having 
five or more of the nine symptoms of VS listed in the 
questionnaire. Interestingly, 13 (87%) of these 15 individuals 
also indicated that their VS symptoms were present well 
prior to the onset of their CFS symptoms. 
Prevalence of visual stress symptoms in the chronic 
fatigue syndrome and visual stress groups
The presence of each symptom of VS in the CFS group was 
compared to its respective frequency in the group of 
participants expected to have such symptoms, namely, the 
VS-diagnosed group. Statistical analysis of the data revealed 
no significant differences between the CFS and VS groups 
concerning seven of the nine diagnostic symptoms of VS 
which were surveyed (Table 2). The two exceptions were 
the symptoms: “Print distortions, especially with black 
print on white paper” (p = 0.008) and “Preference for 
reading text printed on coloured paper” (p = .005). In both 
instances, the VS group reported significantly higher 
frequencies of these symptoms than did the CFS group.
Discussion
The purpose of this study was to carry out a preliminary 
investigation of the extent to which symptoms of VS are 
present in individuals with CFS. It was further anticipated 
that if symptoms of VS were reported by subjects diagnosed 
with CFS, it would be likely that the VS symptoms were 
present prior to the onset of their CFS symptoms. The basis 
for this expectation was that VS is a congenital disorder 
which has been shown to have a high heritability index 
(Robinson et al., 1995), whereas CFS is a disorder that is 
more commonly reported in adults than in children and 
young adolescents. Consistent with this expectation, 18 
(90%) of the CFS subjects (n = 20) indicated in the survey 
that the symptoms of VS they had acknowledged were 
either present since childhood, or first became present at 
the same time as the onset of their CFS symptoms. 
Results from the present study showed that all nine VS 
symptoms surveyed were significantly more represented in 
Table 1 Presence of VS symptoms in the CFS and comparison groups: (no. of subjects; % of group; significance of variation).
Symptom CFS group Comparison group χ2 
 (n = 20) (n = 46)
Slow reading 10 (50%) 10 (22%) 5.27*
Strain & fatigue with extended reading 17 (85%) 20 (44%) 9.76*
Print distortions, esp. with black print on white paper 8 (40%) 7 (15%) 4.88*
Preference for reading text printed on coloured paper 6 (30%) 3 (7%) 6.52*
Lack of depth perception or difficulty in judging distances 11 (55%) 7 (15%) 11.12*
A feeling of clumsiness when negotiating uneven terrain 13 (65%) 8 (17%) 14.56*
Dislike of bright light or glare (photophobia) 14 (70%) 19 (41%) 4.59*
Dislike of reading/writing under fluorescent lighting 17 (85%) 13 (28%) 18.10*
Difficulty maintaining train of thought during conversation 16 (80%) 18 (39%) 9.32*
Note. The table shows that the CFS group reported significantly increased frequencies of all nine symptoms of VS surveyed.
 *p < .05; CFS = Chronic fatigue syndrome.
Table 2 Presence of VS symptoms in the CFS and VS groups: (no. of subjects; % of group; significance of variation).
Symptom CFS group VS group χ2 
 (n = 20) (n = 14) 
Slow reading 10 (50%) 11 (79%) 2.85
Strain & fatigue with extended reading 17 (85%) 13 (93%) 0.49
Print distortions, esp. with black print on white paper 8 (40%) 12 (86%) 7.11*
Preference for reading text printed on coloured paper 6 (30%) 11 (79%) 7.77*
Lack of depth perception or difficulty in judging distances 11 (55%) 9 (64%) 0.29
A feeling of clumsiness when negotiating uneven terrain 13 (65%) 6 (43%) 1.64
Dislike of bright light or glare (photophobia) 14 (70%) 9 (64%) 0.12
Dislike of reading/writing under fluorescent lighting 17 (85%) 11 (79%) 0.23
Difficulty maintaining train of thought during conversation 16 (80%) 11 (79%) 0.01
Note. The table shows statistically significant between-group differences concerning only two of the nine VS symptoms.
 *p < .05; CFS = Chronic fatigue syndrome; VS = Visual stress.
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the CFS group than in the comparison group of healthy 
adults. The study also found that there were no significant 
differences between the CFS and VS groups in the 
frequencies of seven of the VS symptoms. The findings 
therefore indicated that the presence of symptoms of VS in 
subjects diagnosed with CFS is far greater than previously 
reported. A plausible explanation could be the existence of 
a common underlying factor (or factors) in both conditions. 
The symptoms of VS that did vary significantly in 
presence between the CFS and VS groups were the 
symptoms of ‘Print distortions, especially with black print 
on white paper’ and ‘Preference for reading text printed on 
coloured paper’. However, it is possible that this 
difference was due to awareness of the nature of VS by 
those who have been diagnosed with the condition. Firstly, 
almost all text is printed with black ink on white paper, 
and it is thus likely that most people seldom have the 
opportunity to notice if reading from non-white paper 
reduces print distortions and/or if coloured paper is 
preferable. Secondly, individuals with VS are routinely 
advised upon diagnosis that the use of coloured or even 
off-white paper when reading, in place of contemporary 
ultra-white paper, can greatly reduce the intensity of 
their symptoms (Irlen, 1994; Wilkins, Huang, & Cao, 2004). 
Thus, all individuals in the study’s VS-diagnosed group 
were probably aware of the possible benefits of coloured 
paper for reading discomfort, and this could have 
potentially skewed the results of the comparisons between 
the CFS and VS groups relating to these two symptoms. 
The fact remains, however, that the frequencies of seven 
of the nine diagnostic symptoms of VS surveyed in in the 
CFS group were remarkably similar to frequencies in the VS 
group. In considering this, and because the manifestations 
of CFS include a large neurological component which can 
affect sensory stimulation and VS is a neurological disorder 
affecting the visual system, it would seem reasonable to 
postulate that common physiological mechanisms may play 
a role in both conditions. It may even be possible that 
certain factors causing morbidity for one syndrome might 
predispose an affected individual to subsequent 
development of the other syndrome. Indeed, in an earlier 
study investigating biochemical anomalies in CFS, Robinson 
et al. (2001) reported that 38 (62%) of their CFS subjects 
(n = 61) were identified as having moderate to severe 
symptoms of VS, while in the general population VS is 
estimated to affect 5-12% of individuals. That study also 
found that anomalies in metabolite levels (particularly 
lipids) correlated strongly with the intensity of VS symptoms 
reported by the CFS subjects. 
In the present CFS group (n = 20), 15 (75%) of the subjects 
reported experiencing five or more of the nine VS symptoms 
surveyed. The data relating to the histories of VS and CFS 
symptoms in this sub-group indicated that the onset of 
CFS is perhaps more likely to occur in individuals with 
a life-long history of VS symptoms. Of the above 
15 individuals: 8 (53%) reported that their symptoms of VS 
were present since childhood and well before the onset of 
CFS; a further 5 (33%) subjects reported first experiencing 
VS symptoms at the same time as the onset of CFS; and 
only 2 (13%) subjects stated that the onset of CFS had 
clearly preceded their symptoms of VS. Thus, if future 
research were to identify common underlying factors in CFS 
and VS, then the symptom histories of the participants in 
this study suggest that in most cases of CFS-VS comorbidity 
the preceding condition would likely be VS. 
It is recognized that limitations of the present study 
include the relatively small numbers of participants in the 
CFS and VS groups. Nevertheless, previous research has 
shown that even a small number of subjects can provide 
data of statistical significance. A comprehensive medical 
history of each participant would have provided additional 
information, and genetic predisposition (e.g., heritability) 
could have been more readily implied if a family history 
was available. Biochemical data from participants would 
also have provided useful information, for example, lipid 
profiles of HDL/LDL cholesterol, triacylglycerides and 
omega-3/6 fatty acids may have identified possible 
correlations of lipid metabolism and the syndromes under 
investigation. Assessments of the presence of CFS symptoms 
in the VS group could have clarified if an overlapping of the 
symptoms of both disorders exists, however, though one of 
the researchers in the present study was qualified to design 
a scientific survey of VS symptoms and to screen for VS 
morbidity, none of the researchers were certified to 
diagnose or evaluate CFS symptomology.
In summary, our preliminary findings indicated that nine 
recognised symptoms of VS were far more frequent in the 
CFS subjects than in the comparison group, and that each 
of these variations was statistically significant. In marked 
contrast, when the frequencies of VS symptoms in the CFS 
group were compared to those reported by the group of 
subjects diagnosed with VS, the variations between the 
groups in seven (78%) of the symptoms were not statistically 
significant. If future research should confirm that 
comorbidity between the VS and CFS disorders is 
exceptionally high, then the lifetime duration and higher 
prevalence of VS perhaps suggest that the underlying causes 
of that disorder might predispose certain individuals to the 
subsequent development of CFS. However, larger scale 
studies including comprehensive clinical data of participants 
are needed to determine if CFS symptoms may also occur in 
VS subjects and, if confirmed, to differentiate ‘symptom 
overlap’ from ‘comorbidity’ in these conditions. In addition, 
future research investigating whether children diagnosed 
with VS have an increased risk of developing CFS in 
adulthood is particularly warranted. 
References
Allen, P. M., Evans, B. J. W., & Wilkins, A. J. (2012). The uses of 
colour in optometric practice to ameliorate symptoms of visual 
stress. Optometry in Practice, 13, 1-8.
Allen, P. M., & Hollis, J. (2008). Meares-Irlen syndrome – a need for 
increasing awareness in the general public. Ophthalmic and 
Physiological Optics, 28, 291-292. 
Declaration of Helsinki [World Medical Association] (2008). 7th revi-
sion of the Declaration of Helsinki: Ethical principles for medi-
cal research involving human subjects. 59th World Medical As-
sociation (WMA) General Assembly, October, 2008, Seoul 
[accessed 8 Jan 2014]. Available from: http://www.wma.net/
en/30publications/10policies/b3/17c.pdf
Evans, B. J. W., & Joseph, F. (2002). The effect of coloured filters 
on the rate of reading in an adult student population. Ophthal-
mic and Physiological Optics, 22, 535-545. 
92 S.J. Loew et al.
Hartley, J. (2012). New ways of making academic articles easier to 
read. International Journal of Clinical and Health Psychology 
12, 143-160.
Huang, J., Zong, X., Wilkins, A., Jenkins, B., Bozoki, A., & Cao, Y. 
(2011). fMRI evidence that precision ophthalmic tints reduce 
cortical hyperactivation in migraine. Cephalalgia, 31, 925-936. 
Irlen, H. (1994). Scotopic sensitivity/Irlen syndrome: Hypothesis 
and explanation of the syndrome. Journal of Behavioral Optom-
etry, 5, 62-65. 
Kriss, I., & Evans, B. J. W. (2005). The relationship between dys-
lexia and Meares-Irlen syndrome. Journal of Research in Read-
ing, 28, 350-364.
Kruk, R., Sumbler, K., & Willows, D. (2008). Visual processing char-
acteristics of children with Meares-Irlen syndrome. Ophthalmic 
and Physiological Optics, 28, 35-46. 
Loew, S. J., Fernández, E., & Watson, K. (2013). Incidence of 
Meares-Irlen/visual stress syndrome in reading and learning dis-
orders: Does fluorescent lighting in classrooms affect literacy 
and numeracy? Aula Abierta, 41, 23-32.
Loew, S. J., & Watson, K. (2012a). A prospective genetic marker of 
the visual perception disorder Meares-Irlen syndrome. Percep-
tual and Motor Skills, 114, 870-882. 
Loew, S. J., & Watson, K. (2012b). Spectral filtering of fluorescent 
lighting: Effects upon reading and visual discomfort in slow 
readers. In J. A. Gonzalez-Pienda, C. Rodriguez, D. Alvarez, R. 
Cerezo, E. Fernandez, M. Cueli, T. Garcia, E. Tuero, & N. Suarez. 
(Eds.), Learning disabilities: Present and future (pp. 267-278). 
Massachusetts: Learning Disabilities WorldWide®. 
Loew, S. J., & Watson, K. (2013). The prevalence of scotopic sensi-
tivity/Meares-Irlen syndrome in subjects diagnosed with ADHD: 
does misdiagnosis play a role? Croatian Review of Rehabilitation 
Research, 49, 50-58.
Ludlow, A. K., Taylor-Whiffen, E., & Wilkins, A. J. (2012). Coloured 
filters enhance the visual perception of social cues in children 
with autism spectrum disorders. ISRN Neurology, 2012. 
doi:10.5402/2012/298098.
Northway, N., Manahilov, V., & Simpson, W. A. (2010). Coloured fil-
ters improve exclusion of perceptual noise in visually sympto-
matic dyslexics. Journal of Research in Reading, 33, 223-230.
Ramus, F., Rosen, S., Dakin, S. C., Day, B. L., Castellote, J. M., 
White, S., & Frith, U. (2003). Theories of developmental dys-
lexia: Insights from a multiple case study of dyslexic adults. 
Brain, 126, 841-65.
Reyes, M., Nisenbaum, R., Hoaglin, D. C., Unger, E. R., Emmons, C., 
Randall, B., Stewart, J. A., Abbey, S., Jones, J. F., Grantz, N., 
Minden, S., & Reeves, W. C. (2003). Prevalence and incidence of 
chronic fatigue syndrome in Wichita, Kansas. Archives of Inter-
nal Medicine, 163, 1530-1536.
Ritchie, S. J., Della Sala, S., & McIntosh, R. D. (2011). Irlen colored 
overlays do not alleviate reading difficulties. Pediatrics, 128, 
e932-e938.
Robinson, G. L. (1994). Coloured lenses and reading: A review of re-
search into reading achievement, reading strategies and causal 
mechanisms. Australian Journal of Special Education, 18, 3-14.
Robinson, G. L. W., & Conway, R. N. F. (2000). Irlen lenses and 
adults: A small scale study of reading speed, accuracy, compre-
hension and self-image. Australian Journal of Learning Disabili-
ties, 5, 4-13.
Robinson, G. L., Hopkins, B. R., & Davies, T. (1995). The incidence 
of symptoms of Scotopic Sensitivity Syndrome in secondary 
school populations: A preliminary study. The Bulletin for Learn-
ing Disabilities, 5, 36-56.
Robinson, G. L., McGregor, N. R., Roberts, T. K., Dunstan, R. H., & 
Butt, H. (2001). A biochemical analysis of people with chronic fa-
tigue who have Irlen syndrome: Speculation concerning immune 
system dysfunction. Perceptual and Motor Skills, 93, 486-504. 
Rodríguez-Pérez, C., González-Castro, P., Álvarez, L., Álvarez, D., 
& Fernández-Cueli, M. S. (2012). Neuropsychological analysis of 
the difficulties in dyslexia through sensory fusion. International 
Journal of Clinical and Health Psychology, 12, 69-80.
Skoyles, J., & Skottun, B. C. (2004). On the prevalence of magno-
cellular deficits in the visual system of non-dyslexic individuals. 
Brain & Language, 88, 79-82. 
Skoyles, J., & Skottun, B. C. (2008). Coherent motion, magnocellu-
lar sensitivity and the causation of dyslexia. The International 
Journal of Neuroscience, 118, 185-190.
Solan, H. A., Shelley-Tremblay, J. F., Hansen, P. C., & Larson, S. 
(2007). Is there a common linkage among reading comprehen-
sion, visual attention, and magnocellular processing? Journal of 
Learning Disabilities, 40, 270-278.
Sparkes, D. L., Robinson, G. L., Roberts, T. K., & Dunstan, R. H. 
(2006). General health and associated biochemistry in a visual-
perceptual sub-type of dyslexia. In S. V. Randall (Ed.), Learning 
Disabilities: New Research (pp. 81-98). New York: Nova Science 
Publications. 
Stein, J. (2003). Visual motion sensitivity and reading. Neuropsych-
ologia, 41, 1785-1793. 
Taurines, R., Schmitt, J., Renner, T., Conner, A. C., Warnke, A., & 
Romanos, M. (2010). Developmental comorbidity in attention-
deficit/hyperactivity disorder. ADHD-Attention Deficit Hyperac-
tivity Disorder, 2, 267-289. 
White, S., Milne, E., Rosen, S., Hansen, P., Swettenham, J., Frith, 
U., & Ramus, F. (2006). The role of sensorimotor impairments in 
dyslexia: a multiple case study of dyslexic children. Develop-
mental Science, 9, 237-55.
Whiting, P. R., Robinson, G. L. W., & Parrott, C. F. (1994). Irlen col-
oured filters for reading: A six year follow-up. Australian Journal 
of Remedial Education, 26, 13-19.
Wilkins, A. J., & Evans, B. J. W. (2009). Visual stress, its treatment 
with spectral filters, and its relationship to visually induced mo-
tion sickness. Applied Ergonomics, 41, 509-515.
Wilkins, A. J., Huang, J., & Cao, Y. (2004). Visual stress theory and 
its application to reading and reading tests. Journal of Research 
in Reading, 27, 152-162.
Wilkins, A. J., Huang, J., & Cao, Y. (2007). Prevention of visual 
stress and migraine with precision spectral filters. Drug Devel-
opment Research, 68, 469-475.
Winterbottom, M., & Wilkins, A. J. (2009). Lighting and discomfort in 
the classroom. Journal of Environmental Psychology, 29, 63-75. 
Wright, C. M., & Conlon, E. G. (2009). Auditory and visual process-
ing in children with dyslexia. Developmental Neuropsychology, 
34, 330-355.
